In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
about
Long-term delivery of protein therapeuticsNoninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imagingFormulation and evaluation of injectable in situ forming microparticles for sustained delivery of lornoxicam.Silk constructs for delivery of musculoskeletal therapeutics.Leuprolide acetate: pharmaceutical use and delivery potentials.Formulation strategies for sustained release of proteins.Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.PLA micro- and nano-particles.The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants.In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies.Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer.Development of oral suspensions of microparticles of ethylcellulose with tramadol.Impact of microparticle formulation approaches on drug burst release: a level A IVIVC.In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
P2860
Q26860505-A0F858CC-05AE-4C8F-B7AC-147C35A37864Q30460008-E77279D2-5BCA-4024-8B20-12CBB7E30B4CQ36145533-70B8E81E-A7C1-4827-A8AA-575A705E379BQ37035579-7BDAD2FF-50B7-40B5-80ED-78F78480A50BQ37984084-BE639D13-52E1-4F17-8FBF-AAEADBE3E5F5Q38027859-A75C4AE4-CC67-430A-A931-238799B9F06AQ38783457-4C005C27-CC61-4CE5-B5BB-C866537708BAQ38855152-AEA57532-A81A-4525-93EC-2D819FCD58FDQ38917755-55697169-DDD6-4696-9184-9E9ADFCD77E1Q38918467-F6201D27-89C4-4B19-B9E1-2CCC7B86C8D8Q39003600-3B90066D-E121-4D02-86F3-21327FF5E6C7Q43149698-CE396451-7D6A-48B3-8EAA-8E184DE5B6A0Q46897568-11F45B62-F36F-46F6-ABDA-1BCE52F77720Q53650083-C8D80F3F-FDBC-4E87-A682-5A807EF42E25
P2860
In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In situ forming microparticle ...... ion and processing parameters.
@en
In situ forming microparticle ...... ion and processing parameters.
@nl
type
label
In situ forming microparticle ...... ion and processing parameters.
@en
In situ forming microparticle ...... ion and processing parameters.
@nl
prefLabel
In situ forming microparticle ...... ion and processing parameters.
@en
In situ forming microparticle ...... ion and processing parameters.
@nl
P1476
In situ forming microparticle ...... ion and processing parameters.
@en
P2093
Roland Bodmeier
Xiaosong Luan
P304
P356
10.1016/J.EJPS.2005.09.002
P407
P577
2005-10-21T00:00:00Z